Molecular Cancer (Jan 2021)

Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity

  • Yann Cheli,
  • Meri K. Tulic,
  • Najla El Hachem,
  • Nicolas Nottet,
  • Arnaud Jacquel,
  • Maeva Gesson,
  • Thomas Strub,
  • Karine Bille,
  • Alexandra Picard-Gauci,
  • Henri Montaudié,
  • Guillaume E. Beranger,
  • Thierry Passeron,
  • Pierre Close,
  • Corine Bertolotto,
  • Robert Ballotti

DOI
https://doi.org/10.1186/s12943-021-01319-5
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 1

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.